RESUMEN
Olfaction and food intake are interrelated and regulated. In the process of feeding, the metabolic signals in the body and the feeding signals produced by food stimulation are first sensed by the arcuate nucleus of hypothalamus and the nucleus tractus solitarius of brain stem, and then these neurons project to the paraventricular nucleus of hypothalamus. The paraventricular nucleus transmits the signals to other brain regions related to feeding and regulates feeding behavior. In this process, olfactory signals can be transmitted to hypothalamus through olfactory bulb and olfactory cortex to regulate feeding behavior. At the same time, gastrointestinal hormones (ghrelin, insulin, leptin, etc.) and some neurotransmitters (acetylcholine, norepinephrine, serotonin, endocannabinoid, etc.) produced in the process of feeding act on the olfactory system to regulate olfactory function, which in turn affects the feeding itself. This review summaries the research progress of the interaction between olfaction and food intake and its internal mechanism from the aspects of neuronal and hormonal regulation.
Asunto(s)
Núcleo Arqueado del Hipotálamo/metabolismo , Conducta Alimentaria/fisiología , Hipotálamo , Núcleo Hipotalámico Paraventricular , OlfatoRESUMEN
OBJECTIVE@#To explore the association of single nucleotide polymorphisms (SNPs) of the vitamin D receptor gene ( VDR) with circulating lipids considering gender differences.@*METHODS@#Of the Han Chinese adults recruited from a health examination center for inclusion in the study, the circulating lipids, 25-hydroxyvitamin D (25OHD), and other parameters were measured. The VDR SNPs of Cdx2 (rs11568820), Fok1 (rs2228570), Apa1 (rs7975232), and Taq1 (rs731236) were genotyped with a qPCR test using blood DNA samples, and their associations with lipids were analyzed using logistic regression.@*RESULTS@#In the female participants ( n = 236 with dyslipidemia and 888 without dyslipidemia), multiple genotype models of Fok1 indicated a positive correlation of B (not A) alleles with LDLC level ( P < 0.05). In the male participants ( n = 299 with dyslipidemia and 564 without dyslipidemia), the recessive model of Cdx2 and the additive and recessive models of Fok1 differed ( P < 0.05) between the HDLC-classified subgroups, respectively, and Fok1 BB and Cdx2 TT presented interactions with 25OHD in the negative associations with HDLC ( P < 0.05).@*CONCLUSION@#In the Chinese Han adults included in the study, the Fok1 B-allele of VDR was associated with higher LDLC in females, and the Fok1 B-allele and the Cdx2 T-allele of VDR were associated with lower HDLC in males. The interaction of VD and Fok1 BB or Cdx2 TT in males synergistically decreased HDLC levels.
Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Alelos , Pueblo Asiatico/genética , China/etnología , Dislipidemias/genética , Predisposición Genética a la Enfermedad/genética , Genotipo , Lípidos/sangre , Polimorfismo de Nucleótido Simple , Receptores de Calcitriol/genética , Factores Sexuales , Vitamina D/sangreRESUMEN
Objective: To investigate the effect of aryl hydrocarbon receptor (AHR) RNA interference on hepatoma HCCLM3 cell proliferation and migration and to explore its possible mechanism. Methods: After HCCLM3 cells transfection with specific AHR-small interference RNA (siRNA), the expression level of AHR mRNA was detected by real-time fluorescence quantitative-PCR, and the expression levels of AHR, stress-activated protein kinases (SAPK)/c-Jun N-terminal kinase (JNK), extracellular signal-regulated kinase 1/2 (ERK 1/2) and c-Jun phosphorylation were detected by Western blotting. Then the proliferation and migration of HCCLM3 cells after transfection with AHR-siRNA were detected by cell counting kit-8 (CCK-8) and Transwell assay, respectively. Synthesize AHR gene-specific small hairpin RNA (shRNA) to construct recombinant virus vector pMKO.1/puro-shAHR which stable knockdown AHR, and the recombinant vector was infected into HCCLM3 cells and then implanted into nude mice to construct subcutaneous tumor model. The growth of xenografted tumor in nude mice was examined. The expression levels of AHR protein in HCCLM3 cells and xenografted tumor tissues after infection with pMKO.1/puro-shAHR were detected by Western blotting. Results: The expression levels of AHR mRNA and protein were significantly reduced in HCCLM3 cells transfected with AHR-siRNA (P < 0.01), and the proliferation and migration of HCCLM3 cells were inhibited (P < 0.01). The expression levels of SAPK/JNK, ERK 1/2 and c-Jun phosphorylation were depressed (P < 0.01). The volume and weight of HCCLM3 cells xenografted tumor in nude mice after infection with pMKO.1/puro-shAHR were lower than those of the control group (HCCLM3 cells were infected with pMKO.1/puro-shNC) (P < 0.01). The expression levels of AHR protein in HCCLM3 cells and xenografted tissues after infection with pMKO.1/puro-shAHR were decreased (P < 0.01). Conclusion: AHR may promote HCCLM3 cell proliferation and migration in vitro by up-regulating the phosphorylation levels of ERK1/2, SAPK/JNK and c-Jun. Copyright © 2014 by TUMOR.
RESUMEN
COVID-19 is characterised by dysregulated immune responses, metabolic dysfunction and adverse effects on the function of multiple organs. To understand how host responses contribute to COVID-19 pathophysiology, we used a multi-omics approach to identify molecular markers in peripheral blood and plasma samples that distinguish COVID-19 patients experiencing a range of disease severities. A large number of expressed genes, proteins, metabolites and extracellular RNAs (exRNAs) were identified that exhibited strong associations with various clinical parameters. Multiple sets of tissue-specific proteins and exRNAs varied significantly in both mild and severe patients, indicative of multi-organ damage. The continuous activation of IFN-I signalling and neutrophils, as well as a high level of inflammatory cytokines, were observed in severe disease patients. In contrast, COVID-19 in mild patients was characterised by robust T cell responses. Finally, we show that some of expressed genes, proteins and exRNAs can be used as biomarkers to predict the clinical outcomes of SARS-CoV-2 infection. These data refine our understanding of the pathophysiology and clinical progress of COVID-19 and will help guide future studies in this area.
RESUMEN
At the end of 2019 Wuhan witnessed an outbreak of "atypical pneumonia" that later developed into a global pandemic. Metagenomic sequencing rapidly revealed the causative agent of this outbreak to be a novel coronavirus - SARS-CoV-2. Herein, to provide a snapshot of the pathogens in pneumonia-associated respiratory samples from Wuhan prior to the emergence of SARS-CoV-2, we collected bronchoalveolar lavage fluid samples from 408 patients presenting with pneumonia and acute respiratory infections at the Central Hospital of Wuhan between 2016 and 2017. Unbiased total RNA sequencing was performed to reveal their "total infectome", including viruses, bacteria and fungi. Consequently, we identified 37 pathogen species, comprising 15 RNA viruses, 3 DNA viruses, 16 bacteria and 3 fungi, often at high abundance and including multiple co-infections (12.8%). However, SARS-CoV-2 was not present. These data depict a stable core infectome comprising common respiratory pathogens such as rhinoviruses and influenza viruses, an atypical respiratory virus (EV-D68), and a single case of a sporadic zoonotic pathogen - Chlamydia psittaci. Samples from patients experiencing respiratory disease on average had higher pathogen abundance than healthy controls. Phylogenetic analyses of individual pathogens revealed multiple origins and global transmission histories, highlighting the connectedness of the Wuhan population. This study provides a comprehensive overview of the pathogens associated with acute respiratory infections and pneumonia, which were more diverse and complex than obtained using targeted PCR or qPCR approaches. These data also suggest that SARS-CoV-2 or closely related viruses were absent from Wuhan in 2016-2017.
RESUMEN
Emerging and re-emerging infectious diseases, such as SARS, MERS, Zika and highly pathogenic influenza present a major threat to public health1-3. Despite intense research effort, how, when and where novel diseases appear are still the source of considerable uncertainly. A severe respiratory disease was recently reported in the city of Wuhan, Hubei province, China. At the time of writing, at least 62 suspected cases have been reported since the first patient was hospitalized on December 12nd 2019. Epidemiological investigation by the local Center for Disease Control and Prevention (CDC) suggested that the outbreak was associated with a sea food market in Wuhan. We studied seven patients who were workers at the market, and collected bronchoalveolar lavage fluid (BALF) from one patient who exhibited a severe respiratory syndrome including fever, dizziness and cough, and who was admitted to Wuhan Central Hospital on December 26th 2019. Next generation metagenomic RNA sequencing4 identified a novel RNA virus from the family Coronaviridae designed WH-Human-1 coronavirus (WHCV). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that WHCV was most closely related (89.1% nucleotide similarity similarity) to a group of Severe Acute Respiratory Syndrome (SARS)-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) previously sampled from bats in China and that have a history of genomic recombination. This outbreak highlights the ongoing capacity of viral spill-over from animals to cause severe disease in humans.